131 related articles for article (PubMed ID: 26049698)
41. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
[TBL] [Abstract][Full Text] [Related]
42. Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.
Kelly KA; Hollingsworth MA; Brand RE; Liu CH; Singh VK; Srivastava S; Wasan AD; Yadav D; Andersen DK
Pancreas; 2015 Nov; 44(8):1185-94. PubMed ID: 26465948
[TBL] [Abstract][Full Text] [Related]
43. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.
Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H
Tumour Biol; 2016 Feb; 37(2):1699-705. PubMed ID: 26311050
[TBL] [Abstract][Full Text] [Related]
44. Challenges of Pancreatic Cancer.
Dimastromatteo J; Houghton JL; Lewis JS; Kelly KA
Cancer J; 2015; 21(3):188-93. PubMed ID: 26049698
[TBL] [Abstract][Full Text] [Related]
45. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
46. Early Cancer Detection at the Epithelial Surface.
Rogalla S; Contag CH
Cancer J; 2015; 21(3):179-87. PubMed ID: 26049697
[TBL] [Abstract][Full Text] [Related]
47. New developments in the early diagnosis of pancreatic cancer.
Zhang Q; Chen S; Zeng L; Chen Y; Lian G; Qian C; Li J; Xie R; Huang KH
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):149-156. PubMed ID: 27937041
[TBL] [Abstract][Full Text] [Related]
48. Biomarkers for early diagnosis of pancreatic cancer.
Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
[TBL] [Abstract][Full Text] [Related]
49. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.
Gast CE; Silk AD; Zarour L; Riegler L; Burkhart JG; Gustafson KT; Parappilly MS; Roh-Johnson M; Goodman JR; Olson B; Schmidt M; Swain JR; Davies PS; Shasthri V; Iizuka S; Flynn P; Watson S; Korkola J; Courtneidge SA; Fischer JM; Jaboin J; Billingsley KG; Lopez CD; Burchard J; Gray J; Coussens LM; Sheppard BC; Wong MH
Sci Adv; 2018 Sep; 4(9):eaat7828. PubMed ID: 30214939
[TBL] [Abstract][Full Text] [Related]
50. A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts.
Rochefort MM; Girgis MD; Knowles SM; Ankeny JS; Salazar F; Wu AM; Tomlinson JS
Mol Imaging Biol; 2014 Oct; 16(5):721-9. PubMed ID: 24691872
[TBL] [Abstract][Full Text] [Related]
51. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer.
Shin SJ; Smith JA; Rezniczek GA; Pan S; Chen R; Brentnall TA; Wiche G; Kelly KA
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19414-9. PubMed ID: 24218614
[TBL] [Abstract][Full Text] [Related]
52. Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Viola-Villegas NT; Rice SL; Carlin S; Wu X; Evans MJ; Sevak KK; Drobjnak M; Ragupathi G; Sawada R; Scholz WW; Livingston PO; Lewis JS
J Nucl Med; 2013 Nov; 54(11):1876-82. PubMed ID: 24029655
[TBL] [Abstract][Full Text] [Related]
53. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
[TBL] [Abstract][Full Text] [Related]
54. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.
Foygel K; Wang H; Machtaler S; Lutz AM; Chen R; Pysz M; Lowe AW; Tian L; Carrigan T; Brentnall TA; Willmann JK
Gastroenterology; 2013 Oct; 145(4):885-894.e3. PubMed ID: 23791701
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
